UnicomIG
0.1.0 - ci-build
UnicomIG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/unicom-ig/ and changes regularly. See the Directory of published versions
Full name: Canifug Cremolum
- Invented name part: Canifug Cremolum
Name usage: Estonian (Republic of Estonia)
Authorised dose form: Cream + pessary
Legal status of supply: Medicinal Product subject to medical prescription
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 366201
Region: Republic of Estonia
Marketing authorisation holder: Dr. August Wolff GmbH & Co. KG Arzneimittel
Identifier:
Status: Valid - Renewed/Varied (2011-10-19)
Package 1 of 1
PCID: EE-100004795-10280-1033692
Description: Alu/PE-fooliumist valmistatud ribapakend, mis on asetatud väliskarpi. Kreem on alumiiniumtuubis ja omakorda pappkarbis. Kombineeritud pakend sisaldab: 6 vaginaalsuposiiti ja 20 g kreemi
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 1 Strip (Aluminium) (PolyEthylene)
Containing: 6
Manufactured Item
Dose form: Pessary
Unit of presentation: Pessary
Ingredient
Role: Active
Substance: CLOTRIMAZOLE
Presentation strength: 100 milligram(s) / 1 Pessary
Package: 1 Tube (Aluminium)
Containing: 20 gram(s)
Manufactured Item
Dose form: Cream
Unit of presentation: Tube
Ingredient
Role: Active
Substance: CLOTRIMAZOLE
Concentration strength: 10 milligram(s) / 1 gram(s)
Administrable Product (1 of 2)
Dose form: Cream
Unit of presentation: Tube
Route of administration:
Ingredient
Role: Active
Substance: CLOTRIMAZOLE
Concentration strength: 10 milligram(s) / 1 gram(s)
Administrable Product (2 of 2)
Dose form: Pessary
Unit of presentation: Pessary
Route of administration:
Ingredient
Role: Active
Substance: CLOTRIMAZOLE
Presentation strength: 100 milligram(s) / 1 Pessary